Noteworthy events during the week of July 28 – August 3 for healthcare investors.
MONDAY (7/29): American Heart Association Basic Cardiovascular Sciences Scientific Sessions, Boston (2 days). Cytokinetics (NASDAQ:CYTK): Preclinical data on CK-3773274.
TUESDAY (7/30): Radiation Injury Treatment Network Workshop, Arlington, VA (2 days). Pluristem Therapeutics (NASDAQ:PSTI): Data on PLX-R18 as a countermeasure against acute radiation syndrome.
WEDNESDAY (7/31): Mylan NV (NASDAQ:MYL): Investor Day, NYC.
SATURDAY (8/3): FDA action date for Daiichi Sankyo‘s (OTCPK:DSKYF) pexidartinib for tenosynovial giant cell tumor not amenable for surgical resection.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.